https://www.selleckchem.com/pr....oducts/nvp-cgm097.ht
When administered as ACT, these T cells prolonged median survival of escape variant-bearing mice by 60%. The rational combination of ACT with PD-1 blockade prolonged median survival of escape variant glioma-bearing mice by 110% and was dependent upon natural killer cells and T cells. These findings suggest that the immune landscape of brain tumors are markedly different postimmunotherapy yet can still be targeted with immunotherapy. These findings suggest that the immune landscape of brain tumors are markedly different postimmunother
Like
Comment
Share
